Product Images Memantine Hydrochloride

This is a description of a medication package for Namenda 5mg Tablet, manufactured by Vivimed Life Sciences Pvt Ltd. The package has been prepacked by Bryant Ranck and includes 30 tablets, with expiration date MM/YY. The NDC number is 7133517981. The package has instructions to store at room temperature and a warning to keep out of reach of children. The last line appears to be a barcode or product identification number.*

The text is a table showing the mean change from baseline in ADCS-ADL Score after 12 weeks of treatment with either placebo or Memantine HCI. It also mentions "Clinical Improvement."*

This is a plot showing the cumulative percentage of patients for two different treatments, Placebo and MEMANTINE HCI, with respect to the ADCS-ADL Change from Baseline. The plot indicates that more patients on MEMANTINE HCI experienced a decrease in ADCS-ADL score compared to Placebo.*

The text is describing a graph that shows the cumulative percentage of patients who were given either Placebo or Memantine HCI and the change from baseline in terms of SIB (Severe Impairment Battery) scores. The graph has a scale from -10 to 10, with the increments of 5. However, there is no clear indication of what the graph is intended to show or what it is meant to be used for.*

The provided text seems to be a graphical representation of the "Cumulative Percentage of Patients" over time, illustrated through a chart. It showcases the effect of two treatments "Placebo/Donepezil" and "MEMANTINE HCI/Donepezil" on "ADCS-ADL Change from Baseline" scale. However, without the actual chart, it is not possible to provide more information.*